Core Insights - Vanda Pharmaceuticals has entered into a multi-year partnership with Monumental Sports & Entertainment (MSE), becoming a Founding Partner for the new arena in downtown Washington, D.C. [1][2] - The partnership includes the exclusive entitlement of the Vanda Pharmaceuticals Studio, which will serve as the broadcast center for MSE's sports media platform [3][4]. Partnership Details - Vanda Pharmaceuticals is the second Founding Partner of the Capital One Arena project, joining United Airlines [2]. - The partnership encompasses brand alignment with the NBA's Washington Wizards, NHL's Washington Capitals, and WNBA's Washington Mystics, enhancing MSE's regional media platform [2][4]. Studio and Media Integration - The Vanda Pharmaceuticals Studio, set to open in March 2024, will feature advanced broadcasting technology, including 24 cameras and 1,200 square feet of 4K LED displays [3]. - Vanda will be integrated into all content produced by MSE, including pre- and post-game shows and digital storytelling, reaching millions of fans [4][6]. Community and Brand Impact - Vanda aims to promote growth and community engagement in Washington, D.C., through this partnership, aligning with MSE's vision for innovative community impact [5][6]. - The partnership will enhance Vanda's visibility across various platforms, including branding at the Capital One Arena, which hosts three million guests annually [5][6]. Future Vision - MSE is focused on reimagining the fan experience with cutting-edge technology and immersive design, aiming to inspire millions of visitors over the next 25 years [7].
Monumental Sports & Entertainment Taps D.C.'s Own Vanda Pharmaceuticals as Founding Partner to Help Drive the Creation of Brand-New Downtown Arena